)
Edge17 Oct 2025
A Castle in the Sky: The Story of Oracle
Oracle's journey from database innovator to disciplined enterprise backbone, now shaping the AI buildout with a standardized cloud infrastructure.
Uniphar (UPR) investor relations material
Uniphar H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary2 Sep, 2025
Executive summary
Achieved €1.5 billion revenue, €219.7 million gross profit, and €57.5 million EBITDA in H1 2025, with all divisions contributing to organic growth.
Adjusted EPS grew 21% year-over-year, supported by a €35 million share buyback and interim dividend increase.
ROCE reached 15.5%, exceeding the 12–15% target range.
Continued strategic investments in technology, infrastructure, and people to support medium-term €200 million EBITDA target.
Maintained strong sustainability performance, with AAA MSCI ESG rating and top-10 global healthcare ESG ranking.
Financial highlights
Organic gross profit growth of 8.1% across all divisions; revenue up 8.6% year-over-year to €1,485.5 million.
EBITDA increased 2.9% to €57.5 million; organic EBITDA up 4.9%.
Adjusted EPS at 9.8 cents, up 21%; free cash flow conversion at 35.3%.
Net bank debt at €197.5 million; leverage at 1.9x net bank debt/EBITDA.
Gross margin at 14.8%, EBITDA margin at 3.9%.
Outlook and guidance
Targeting €200 million EBITDA by 2028, with at least 80% of growth expected to be organic.
Free cash flow conversion expected to reach 60–70% by 2028.
Net bank debt/EBITDA not to exceed 2.5x in the medium term.
Progressive dividend policy and continued share buybacks subject to market conditions.
Organic EBITDA acceleration expected in H2 due to revenue phasing and investment timing.
Greenogue 2 dual running period cost impact?
What drives Pharma's future margin expansion?
Medtech BD investment: what triggered timing?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Uniphar earnings date
H2 202524 Feb, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research17 Oct 2025
Beneath the Surface: A Conversation with Epiroc CEO Helena Hedblom
Legacy, innovation, and leading one of Sweden's most influential industrial companies into a new era.
)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Frequently asked questions
Uniphar Public Limited Company is a diversified healthcare services provider, operating mainly in the Republic of Ireland, the United Kingdom, and on an international scale. The company functions through three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. In the Commercial & Clinical segment, Uniphar offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, alongside distribution and support services to medical device manufacturers. The Product Access division delivers services that facilitate access to pharmaco-medical products and treatments, establishing vital connections between manufacturers and healthcare stakeholders, as well as providing bespoke distribution partnerships for pharmaceutical partners. The Supply Chain & Retail division is involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, and operates a network of pharmacies under various brands. Additionally, it provides a range of support services including pharmacy support, specialist nursing, infusion, medical device distribution, healthcare technology, data intelligence, consultancy, pharmaceutical advisory, medical affairs, online pharmacy, and product fostering services. The company is headquartered in Dublin, Ireland, and its shares are listed on the Irish Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage